Xu Stella 4
4 · Design Therapeutics, Inc. · Filed Mar 22, 2022
Insider Transaction Report
Form 4
Xu Stella
Director10% Owner
Transactions
- Sale
Common Stock
2022-03-18$20.34/sh−13,200$268,488→ 4,155,405 total(indirect: See footnote) - Sale
Common Stock
2022-03-18$19.04/sh−552,225$10,514,364→ 4,168,605 total(indirect: See footnote) - Sale
Common Stock
2022-03-21$19.01/sh−24,000$456,240→ 4,131,405 total(indirect: See footnote) - Sale
Common Stock
2022-03-22$18.63/sh−1,455$27,105→ 4,129,950 total(indirect: See footnote)
Holdings
- 10,000(indirect: By Spouse)
Common Stock
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.8726, inclusive. The Reporting Person undertakes to provide the Issuer, and security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.
- [F2]The general partner of Quan Venture Fund II, L.P. is Quan Venture Partners II, L.L.C. Stella Xu is a managing director of Quan Venture Partners II, L.L.C. and shares the ultimate power to vote or dispose of the shares held by Quan Venture Fund II, L.P. Dr. Xu disclaims beneficial ownership of the shares held by Quan Venture Fund II, L.P., except to the extent of her pecuniary interest.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.70, inclusive. The Reporting Person undertakes to provide the Issuer, and security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.30, inclusive. The Reporting Person undertakes to provide the Issuer, and security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.51 to $18.835, inclusive. The Reporting Person undertakes to provide the Issuer, and security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.